Ssi Investment Management LLC Sarepta Therapeutics, Inc. Transaction History

Ssi Investment Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 28, 2021	SELL	$72.25 - $168.95 $103,823 - $242,781	-1,437 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$125.56 - $178.74 $251 - $357	-2 Reduced 0.14%	1,437 $247,000
Q3 2020 Nov 16, 2020	SELL	$127.12 - $172.34 $5,084 - $6,893	-40 Reduced 2.7%	1,439 $204,000
Q2 2020 Aug 12, 2020	BUY	$93.0 - $171.7 $137,547 - $253,944	1,479 New	1,479 $237,000
Q1 2020 May 13, 2020	SELL	$82.38 - $131.64 $127,606 - $203,910	-1,549 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$76.53 - $135.58 $118,544 - $210,013	1,549 New	1,549 $201,000
Q3 2019 Nov 12, 2019	SELL	$72.81 - $156.91 $113,292 - $244,151	-1,556 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$112.21 - $151.95 $174,598 - $236,434	1,556 New	1,556 $237,000

560

85.5M

3.67M

1.75M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Ssi Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ssi Investment Management LLC with notifications on news.